Alaunos Therapeutics Inc

NASDAQ:TCRT  
4.99
+0.06 (+1.15%)
4:47:28 PM EDT: $4.90 -0.09 (-1.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Alaunos Therapeutics Inc Stock, NASDAQ:TCRT

2617 Bissonnet Saint, Suite 225, Houston, Texas 77005
United States of America
Phone: +1.346.355.4099
Number of Employees: 1

Description

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Houston, TX.